Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Daily Archives: January 7, 2020

UNITY Announces End to Epichem Contract

News & Announcements 2020By Richard Mollard January 7, 2020

200107_UNITY Announces End to Epichem Contract

Recent Articles

4 June, Preliminary Monepantel SARS-CoV-2 Data
June 4, 2020
May 31, Top 20 Shareholders
June 1, 2020
PAA Research Report May 2020
May 28, 2020
12 May, Phase II Trial – Successful Anti-Cancer Outcome
May 12, 2020

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust is a clinical-stage company developing novel targeted cancer therapeutics for both humans and animals. ASX: $PAA

Retweet on Twitter PharmAust Retweeted

BioTuesdays @BioTuesdays·

.@PharmAust posted positive preliminary results in experiments aimed at inhibiting the virus that causes COVID-19 https://biotuesdays.com/2020/06/04/pharmaust-lab-tests-show-positive-signs-for-suppressing-covid-19/

Reply on Twitter 1268552094262480897 Retweet on Twitter 12685520942624808972 Like on Twitter 12685520942624808972 Twitter 1268552094262480897

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions